vs
Side-by-side financial comparison of Dexcom (DXCM) and Noble Corp plc (NE). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $764.4M, roughly 1.6× Noble Corp plc). Dexcom runs the higher net margin — 21.2% vs 11.3%, a 9.9% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs -17.6%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 9.5%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Barnes & Noble Booksellers is an American bookseller with the largest number of retail outlets in the United States. The company operates approximately 700+ retail stores across the United States.
DXCM vs NE — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $764.4M |
| Net Profit | $267.3M | $86.6M |
| Gross Margin | 62.9% | — |
| Operating Margin | 25.6% | 5.6% |
| Net Margin | 21.2% | 11.3% |
| Revenue YoY | 21.6% | -17.6% |
| Net Profit YoY | 153.6% | -10.4% |
| EPS (diluted) | $0.67 | $0.54 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $764.4M | ||
| Q3 25 | $1.2B | $798.0M | ||
| Q2 25 | $1.2B | $848.7M | ||
| Q1 25 | $1.0B | $874.5M | ||
| Q4 24 | $1.1B | $927.3M | ||
| Q3 24 | $994.2M | $800.5M | ||
| Q2 24 | $1.0B | $692.8M |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $86.6M | ||
| Q3 25 | $283.8M | $-21.1M | ||
| Q2 25 | $179.8M | $42.9M | ||
| Q1 25 | $105.4M | $108.3M | ||
| Q4 24 | $151.7M | $96.6M | ||
| Q3 24 | $134.6M | $61.2M | ||
| Q2 24 | $143.5M | $195.0M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 5.6% | ||
| Q3 25 | 20.1% | 6.3% | ||
| Q2 25 | 18.4% | 15.9% | ||
| Q1 25 | 12.9% | 21.4% | ||
| Q4 24 | 17.0% | 18.4% | ||
| Q3 24 | 15.3% | 14.4% | ||
| Q2 24 | 15.7% | 30.3% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 11.3% | ||
| Q3 25 | 23.5% | -2.6% | ||
| Q2 25 | 15.5% | 5.1% | ||
| Q1 25 | 10.2% | 12.4% | ||
| Q4 24 | 13.6% | 10.4% | ||
| Q3 24 | 13.5% | 7.6% | ||
| Q2 24 | 14.3% | 28.1% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $0.54 | ||
| Q3 25 | $0.70 | $-0.13 | ||
| Q2 25 | $0.45 | $0.27 | ||
| Q1 25 | $0.27 | $0.67 | ||
| Q4 24 | $0.37 | $0.56 | ||
| Q3 24 | $0.34 | $0.40 | ||
| Q2 24 | $0.35 | $1.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $471.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $4.5B |
| Total Assets | $6.3B | $7.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $471.4M | ||
| Q3 25 | $1.8B | $477.9M | ||
| Q2 25 | $1.2B | $338.2M | ||
| Q1 25 | $904.9M | $303.8M | ||
| Q4 24 | $606.1M | $247.3M | ||
| Q3 24 | $621.2M | $391.9M | ||
| Q2 24 | $939.2M | $162.9M |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $4.5B | ||
| Q3 25 | $2.7B | $4.5B | ||
| Q2 25 | $2.6B | $4.6B | ||
| Q1 25 | $2.3B | $4.7B | ||
| Q4 24 | $2.1B | $4.7B | ||
| Q3 24 | $2.0B | $4.7B | ||
| Q2 24 | $2.4B | $4.0B |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $7.5B | ||
| Q3 25 | $7.5B | $7.6B | ||
| Q2 25 | $7.3B | $7.7B | ||
| Q1 25 | $6.8B | $7.9B | ||
| Q4 24 | $6.5B | $8.0B | ||
| Q3 24 | $6.4B | $8.0B | ||
| Q2 24 | $6.8B | $5.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $187.1M |
| Free Cash FlowOCF − Capex | — | $35.4M |
| FCF MarginFCF / Revenue | — | 4.6% |
| Capex IntensityCapex / Revenue | — | 19.9% |
| Cash ConversionOCF / Net Profit | — | 2.16× |
| TTM Free Cash FlowTrailing 4 quarters | — | $432.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $187.1M | ||
| Q3 25 | $659.9M | $277.1M | ||
| Q2 25 | $303.0M | $216.4M | ||
| Q1 25 | $183.8M | $271.1M | ||
| Q4 24 | $301.4M | $136.2M | ||
| Q3 24 | $199.5M | $283.8M | ||
| Q2 24 | $279.4M | $106.8M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $35.4M | ||
| Q3 25 | $579.4M | $139.5M | ||
| Q2 25 | $208.9M | $99.8M | ||
| Q1 25 | $96.8M | $157.5M | ||
| Q4 24 | $176.8M | $-4.4M | ||
| Q3 24 | $88.3M | $156.8M | ||
| Q2 24 | $213.3M | $-34.3M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 4.6% | ||
| Q3 25 | 47.9% | 17.5% | ||
| Q2 25 | 18.1% | 11.8% | ||
| Q1 25 | 9.3% | 18.0% | ||
| Q4 24 | 15.9% | -0.5% | ||
| Q3 24 | 8.9% | 19.6% | ||
| Q2 24 | 21.2% | -4.9% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 19.9% | ||
| Q3 25 | 6.7% | 17.3% | ||
| Q2 25 | 8.1% | 13.7% | ||
| Q1 25 | 8.4% | 13.0% | ||
| Q4 24 | 11.2% | 15.2% | ||
| Q3 24 | 11.2% | 15.9% | ||
| Q2 24 | 6.6% | 20.4% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 2.16× | ||
| Q3 25 | 2.33× | — | ||
| Q2 25 | 1.69× | 5.05× | ||
| Q1 25 | 1.74× | 2.50× | ||
| Q4 24 | 1.99× | 1.41× | ||
| Q3 24 | 1.48× | 4.64× | ||
| Q2 24 | 1.95× | 0.55× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
NE
| Floaters | $559.8M | 73% |
| Jackups | $145.5M | 19% |
| Service Other | $59.1M | 8% |
